Few rewards for innovation

Published: 2012-04-24 06:57:00

Updated: 2012-04-24 06:57:00

The main reason why companies want the pharmaceutical market and the pricing and reimbursement system to be predictable and transparent is that pharma R&D investment is very long-term and carries a significant risk of failure.

“If the market and achievable prices are not predictable and transparent, the developer of a new drug cannot be certain whether or not his/her investment can be recou...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.